Faron is a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation. The precision immunotherapy in clinical development has the potential to provide permanent immune stimulation for difficult-to-treat cancers through targeting myeloid function.